Galapagos NV, of Mechelen, Belgium, has acquired a structure-based drug discovery service from Sareum of Cambridge, UK, for 695,000 [euro] in cash (US$1 million). The company said the new assets will strengthen …
Комментариев нет:
Отправить комментарий